Cell Death and Disease

Helena-Vieira

Helena L.A. Vieira

Principal Investigator
PhD in Cell Biology, Université Paris VII
Chemical Eng IST, Universidade Técnica de Lisboa

CV

 

Location:

CEDOC
Campus Sant'Ana
Pólo de Investigação, NMS, UNL
Rua Câmara Pestana, nº 6
Lab 3.8
1150-082 Lisboa, Portugal

Phone: (+351) 218 803 101 (Ext: 26009)
Lab ext: 26025
E-mail: helena.vieira(at)nms.unl.pt

Main interests

The main interest is to disclose the biochemical pathways and the molecular target(s) involved in the cytoprotective function of carbon monoxide (CO)/heme-oxygenase (HO) following cerebral hypoxia and ischemia. Our group is also interested in understanding the biochemical processes behind the activation of endogenous mechanisms of defense and conditioning-induced tolerance.

The Cell Death and Disease Lab targets cellular processes including apoptosis, autophagy, metabolic shifts and neuronal differentiation. The objective is to integrate all these cellular processes, with a particular focus on mitochondria and redox signaling. Our approaches include experimental models (rodents and cell culture of brain cells) and human samples (plasma) from healthy volunteers and stroke patients, in close collaboration with Neurology: Stroke & Dementia group.

 
 

Research Areas

Cerebral ischemia
Figure1Stroke is the 1st cause of death in Portugal and 2nd in Europe, leading to enormous social and economical burden. It is caused by the lack of blood supply and the available therapies are based on reperfusion of blood flow with no direct action on brain parenchyma. Furthermore, these therapies present very short time-window for their application, not reaching all stroke patients because their late arrival at hospitals or when stroke onset is not known.
In newborns, perinatal hypoxic-ischemic encephalopathy (HIE) is caused by birth asphyxia or uterine and fetal blood flow interruption, corresponds to 23% of all neonatal deaths worldwide, and is one of the top 20 leading causes of burden of disease in all age groups (WHO). Despite being a disease with an enormous impact, the single approved clinical therapy is hypothermia and also presents a short time window for its application.

Carbon monoxide
Carbon monoxide (CO) is an endogenous gasotransmitter produced by the activity of haem-oxygenase (HO), a stress response enzyme. CO is associated with maintenance of homeostasis and cytoprotection in several tissues, including brain. In fact, CO has anti- apoptotic properties in neurons and in astrocytes, promotes neurogenesis, and reduces neuroinflammation in microglia. Recently, our lab has demonstrated a new biological property of CO: modulation of cell metabolism, which is implicated in prevention of cell death, control of neurogenesis and regulation of inflammation.
Figure2

Remote ischemic conditioning
Figure3Conditioning (also known as hormesis) is a procedure by which a noxious stimulus below damage threshold is applied to a tissue or system. Without causing any damage, endogenous mechanisms of defense are activated, promoting tolerance and cytoprotection. Remote ischemic conditioning (RIC) is the ischemic conditioning of non-vital organs with low-risk (such as arms) that provide protection to another organ (such as the brain). In experimental models, RIC was shown to trigger self-protective pathways in the brain and several potential mechanisms have been postulated: inhibition of neuroinflammation, activation of anti-apoptotic and anti-oxidant pathways, mitochondrial protection and decrease of blood brain barrier permeability.

 
 

Objectives of our research group

(i) The use of endogenous CO or low doses of exogenous CO to target brain parenchyma and improve brain cell function following ischemia and reperfusion. The main targeted molecular mechanisms are: CO control of brain cell metabolism (reinforcement of oxidative metabolism based hypothesis) and CO support on glia-neuron signaling to sustain neuronal plasticity/survival.

(ii) To develop a cost-effective and alternative therapy for stroke patients based on remote ischemic post-conditioning for the activation of endogenous mechanisms of defence and targeting brain parenchyma. Likewise, the underlying mechanisms of remote ischemic conditioning are also under study.

(iii) To identify novel plasma circulating biomarkers for allowing stroke onset prediction and to anticipate long-term prognosis, which is of greater importance for therapy decision and long term clinical planning.

 
 

Experimental models:

• Primary culture of astrocytes, neurons, microglia and cerebral endothelial cells;
• Primary culture and cell lines of cardiomyocytes;
• Human embryonic carcinoma stem cell line;
• Organotypic cultures of hippocampus and cortex;
• Isolated mitochondria from brain and heart (cell free systems);
• In vivo rodent cerebral ischemia (perinatal ischemia)

modelos

Discover more about the Cell Death and Disease Lab:

- O monóxido de carbono tem um papel fundamental na proteção das células neuronais após um AVC isquémico - ep. 476 Helena Vieira 90 Segundos de Ciência

Projects

esquemaImagens-11-e-12-1024x276 - Cópia

 
 
PTDC/MEC-NEU/28750/2017
“BistroPC - Remote ischemic post-conditioning in acute phase of ischemic stroke: disclosing novel circulating biomarkers and clinical trial for improving outcome”
PI: Miguel Viana-Baptista and Co-PI: Helena LA Vieira
 
"Remote ischemic per-conditioning in acute stroke – clinical trial for improving outcome and disclosing novel circulating biomarkers"
Funded by iNOVA4Health Unit
PI: Helena L. A. Vieira and Miguel Viana Baptista
 
 
logo
FCT-ANR/NEU-NMC/0022/2012 - “Translational and mechanistic approaches on carbon monoxide as a modulator of neuroinflammation and neuroprotection in glial cells”
Funded by “Fundação para a Ciência e a Tecnologia” and “Agence Nationale pour la Recherche”
PI: Helena L.A. Vieira and Roberto Motterlini

ANR-FCT/BEX-BCM/0001/2013 - “Mechanisms of cardioprotection by berries driven polyphenols”
Funded by “Fundação para a Ciência e a Tecnologia” and “Agence Nationale pour la Recherche”

PI: Cláudia Santos (iBET) and Catherine Brenner (Université de Paris-Sud)

Municipal Prize for Young Scientists, County of Oeiras 2011 – “Começar em Oeiras” funded by Câmara Municipal de Oeiras, Portugal

COST Action BM 1005 “Gasotransmitters: from basic science to therapeutic applications (ENOG: European Network on Gasotransmitters)” (2011-2014) – Helena L.A: Vieira member of Management Committee.

PTDC/SAU-NEU/089747/2008 - “Preconditioning triggered by Carbon monoxide: new strategies to prevent brain damage due to hypoxia-ischemia and reperfusion”
Funded by “Fundação para a Ciência e a Tecnologia”
PI: Helena L.A. Vieira

PTDC/SAU-NEU/64327/2006 - “Carbon monoxide as neuroprotector against hypoxia-ischemia and reperfusion”
Funded by “Fundação para a Ciência e a Tecnologia”
PI: Helena L.A. Vieira

PTDC/SAU-TOX/112264/2009 - “Chronic Intermittent Eucapnic Hypoxia: systemic effects and evaluation of anti-hypertensive drugs efficacy”
Funded by “Fundação para a Ciência e a Tecnologia”
PI: Emília C. Monteiro

inovaLogoCHLO

Selected Publications

imagem p publicacoes

Book chapters

  • Carlos C. Romão and Helena L. A. Vieira in "Organometallic Chemistry: Recent Advances, ICOMC Silver/Gold Jubilee Book", A. J. L. Pombeiro Editor, J. Wiley, 2013 (in press) ISBN: 9781118510148
  • Carlos C. Romão and Helena L. A. Vieira, Metal Carbonyl Pro-drugs: CO delivery and beyond. in Bioorganometallics, G. Jaouen and M. Salmain Eds, Wiley-VCH, 2nd edition, 2013 in press

Collaborations

 
 

• Miguel Viana-Baptista, MD PhD, CEDOC - See More

• Roberto Motterlini, University of Paris-Est, FRANCE - See more

• Paula M. Alves, PhD Animal Cell Technology Unit, IBET and ITQB Universidade Nova de Lisboa, PORTUGAL - See More

• Alessandro Vercelli, MD PhD, Universidà degli studi di Torino, ITALY - See more

• Catherine Brenner-Jan, PhD, Faculté de Pharmacie, Université de Paris-Sud, France - See more

• Emília Monteiro, MD, PhD, Lisbon Medical School, Universidade Nova de Lisboa, PORTUGAL - See More

• Sílvia Conde, PhD, Lisbon Medical School, Universidade Nova de Lisboa, PORTUGAL - See More

• Patricia Boya, PhD, Centro de Investigaciones Biológicas, CIB-CSIC, Madrid, SPAIN - See more

• Carlos Romão, PhD, ITQB, PORTUGAL - See More

• Carlos Duarte, PhD, Universidade de Coimbra, PORTUGAL - See More at FCTUC or at CNC - See More

Team photos

Foto2

Foto1

Foto3

CEDOC_big_pic-9436

Grupo-2----20-12-2012---3589